JOHNS HOPKINS MEDICINE A drug currently in clinical trials for treating symptoms of Parkinson’s disease may someday have value for treating heart failure, according to results of early animal studies by Johns Hopkins Medicine researchers. The drug, a member of a class of compounds known as phosphodiesterase (PDE) type I inhibitors, shows promising effects on...